The influence of smoking on von Willebrand factor is already manifest in healthy adolescent females: The Floren-teen (Florence Teenager) Study

International Journal of Clinical and Laboratory Research

Volumn 29, Issue 4, 1999, Pages 150-154

  Prisco, D ^a   Fedi, S ^a   Brunelli, T ^a   Chiarugi, L ^a   Lombardi, A ^a   Gianni, R ^b   Santoro, E ^b   Cappelletti, C ^b   Pepe, G ^a,c   Gensini, G F ^a   Abbate, R ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Adolescents; Atherosclerosis; Coagulation; Von Willebrand factor

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ARTERIOSCLEROSIS; ARTICLE; BLOOD; BLOOD CLOTTING; BODY MASS; FEMALE; HUMAN; ITALY; MALE; METABOLISM; PROGNOSIS; RISK FACTOR; SMOKING; SPORT;

ADOLESCENT; ADULT; ARTERIOSCLEROSIS; BLOOD COAGULATION; BODY MASS INDEX; CHOLESTEROL, HDL; FEMALE; HUMANS; ITALY; MALE; PROGNOSIS; RISK FACTORS; SMOKING; SPORTS; TRIGLYCERIDES; VON WILLEBRAND FACTOR;

EID: 6744268020     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005990050082     Document Type: Article

References (38)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990 s. Nature 1993; 362:801.
2. Stamler J, Dyer AR, Shekelle RB, Neaton J, Stamler R. Relationship of baseline major risk factors to coronary and allcause mortality, and to longevity: findings from the long-term follow-up of Chicago cohorts. Cardiology 1993; 82:191.
3. Solberg LA, Strong JP. Risk factors and atherosclerotic lesions: a review of autopsy studies. Arteriosclerosis 1983; 3:187.
4. Newman WP III, Freedmann DS, Voors AW, Gard PD, Srinivasan SR, Cresanta JL, Williamson GD, Webber LS, Berenson GS. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa Heart Study. N Engl J Med 1986; 314:138.
5. Berenson GS, Wattigney WA, Tracy RE, Newman WP III, Sathanur RS, Webber LS, Dalferes ER, Strong JP. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study). Am J Cardiol 1992; 70:851.
6. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking: a preliminary report from the Pathobiolosical Determinants of Atherosclerosis in Youth (PDAY) Research Group. JAMA 1990; 264:3018.
7. McGill HC Jr, Strong JP, Tracy RE, Mc Mahan CA, Oalamann MC. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relation of a postmortem renal index of hypertension to atherosclerosis. Arterioscler Thromb Vasc Biol 1995; 15:222.
8. McGill HC Jr, McMahan CA, Malcom GT, Oalamann MC, Strong JP. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Arterioscler Thromb Vase Biol 1995; 15:431.
9. McGill HC Jr, Mc Mahan CA, Oalamann MC, Strong JP. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. Arterioscler Thromb Vasc Biol 1997; 17:95.
10. Berenson GS, Srinivasan SR, Bao W. Newman WP III, Tracy RE, Wattigney WA for the Bogalusa Heart Study. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 1998; 338:1650.
11. Gensini GF, Comeglio M, Colella A. Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur Heart J 1998; 19 [Suppl A]: A53.
12. Green D, Ruth KJ, Folsom AR, Liu K. Hemostatic factors in the coronary artery risk development in young adults (CARDIA) study. Arterioscler Thromb 1994; 14:686.
13. Sanchez-Bayle M, Cocho P, Baeza J, Vila S, Group JG. Fibrinogen as a cardiovascular risk factor in Spanish children and adolescents. Am Heart J 1993; 126:322.
14. Prisco D, Fedi S, Brunelli T, Cellai AP, Hagi MI, Gianni R, Santoro E, Cappelletti C, Pepe G, Gensini GF, Abbate R. Fibrinogen and factor VIIag in healthy adolescents: the Florenteen (Florence Teenager) study. Thromb Haemost 1996; 75:778.
15. Mannucci PM. von Willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol 1998; 18:1359.
16. Lip GYH, Blann A. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 1997; 34:225.
17. Blann AD, Steele C, McCollum CN. The influence of smoking on soluble adhesion molecules and endothelial cell markers. Thromb Res 1997; 85:433.
18. Egeberg O. Clotting factor levels in patients with coronary atherosclerosis. Scand J Clin Lab Invest 1962; 14:253.
19. Coopberg AA, Teitelbaum JI. The concentration of antihemophilic globulin (AHG) in patients with coronary artery disease. Ann Intern Med 1961; 54:899.
20. Bern MM, Cassani MP, Horton J, Rand L, Davis G. Changes of fibrinolysis and factor VIII coagulant antigen and ristocetin cofactor in diabetes mellitus and atherosclerosis. Thromb Res 1980; 19:831.
21. Rak K, Beck P, Udvadrdy M, Pfliegler G, Misz M, Boda Z. Plasma levels of beta-thromboglobulin and factor VIII-related antigen in diabetic children and adults. Thromb Res 1983; 29:155.
22. Sugrue DD, Trayner I, Thompson GR, Vere VJ, Imeson JD, Stirling Y, Meade TW. Coronary artery disease and hemostatic variables in heterozyeous familial hypercholesterolemia. Br Heart J 1985; 53:265.
23. Myreng Y, Aursnes I, Hjermann I, Stormorken H, Sund T, Helle A. von Willebrand factor and cardiovascular risk. Thromb Res 1986; 314:138.
24. Stormorken H, Erikssen J. Plasma antithrombin III and factor VIII antigen in relation to angiographic findings, angina and blood groups in middle-aged men. Thromb Haemost 1977; 38:874.
25. Hamsten A, Blomback M, Wiman B, Svensson J, Szamosi A, Faire U de, Mettinger L. Haemostatic function in myocardial infarction. Br Heart J, 1986; 55:58.
26. Schmitz-Huebner U, Thompson SG, Balleisen L, Fechtrup C, Grosse-Heitmeyer W, Kirchhof B, Most E, Muller US, Seiffert D, Loo J van de. Lack of association between hemostatic variables and the presence or the extent of coronary atherosclerosis. Br Heart J 1988; 59:287.
27. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, Wu KK. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993; 70:380.
28. Mohlke KL, Ginsburg D. von Willebrand disease and quantitative variation in von Willebrand factor J Lab Clin Med 1997; 130:254.
29. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. BMJ 1976; 2:1525.
30. Blann AD, McCollum CN. Adverse influence of cigarette smoking on the endothelium. Thromb Haemost 1993;70:707.
31. Blann AD, Hopkins J, Winkles J, Wainwright AC. Serum and plasma levels of von Willebrand factor antigen in connective tissue diseases. Ann Clin Biochem 1992; 29:67.
32. Boneu B, Abbal M, Plante J, Bierme R. Factor VIII complex and endothelial damage. Lancet 1975; 1: 1730.
33. Blann AD. Increased circulating levels of von Willebrand factor antigen in smokers may be due to lipid peroxides. Med Sci Res 1991; 19:535.
34. Iso H, Folsom AR, Wu KK, Finch A, Munger RG, Sato S, Shimamoto T, Terao A, Komachi Y. Hemostatic variables in Japanese and Caucasian men. Plasma fibrinogen, factor VIIc, factor VIIIc and von Willebrand and their relations to cardiovascular disease risk factors. Am J Epidemiol 1989; 130:925.
35. Pottinger BE, Read RC, Paleolog EM, Higgins PG, Pearson JD. von Willebrand factor is an acute phase reactant in man. Thromb Res 1989; 53:387.
36. Alien RA, Kluft C, Brommer EJP. Effect of chronic smoking on fibrinolysis. Arteriosclerosis 1985; 5:443.
37. Kaamphuisen PW. Houwing-Duistermaat JJ, Houweling HC van, Eikenboom JCJ, Bertina RM, Roseendal FR. Familial clustering of factor VIII and von Willebrand factor levels. Thromb Haemost 1998; 79:323.
38. Wechsler H, Rigotti NA, Gledhill-Hoyt J, Lee H. Increased levels of cigarette use among college students. A cause for national concern. JAMA 1998; 280:1673.